- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Managed Healthcare Executive® State of Industry Survey: Addressing Health Disparities Seen As a Long Haul
Results of our survey show some tempering of expectation for addressing healthcare disparities and what can be accomplished this year.
The COVID-19 pandemic and the police killing of George Floyd brought long-simmering issues of disparities in health and healthcare to a boil in 2020. There have been countless numbers of reports, studies, talks and programs since, and the Biden administration has made addressing healthcare disparities a priority.
But results of our annual State of Industry show that the ascendant aspirations for addressing healthcare disparities may be plateauing.
Almost half (45%) of the 100 respondents to our survey indicated agreement with the statement that addressing healthcare disparities is admirable but will take a long time to demonstrate an effect and 17% indicated agreement with the statement that addressing healthcare disparities is admirable, but chances of success are small. On the other hand, a large minority (43%) indicated that they agree that addressing them is long overdue.
More evidence of the hopes for addressing healthcare disparities are coming down to earth: A slim majority (51%) of the respondents indicated that they don’t foresee their organization taking meaningful steps to address healthcare disparities in 2022. And a sizable minority (42%) indicated they had very low or low expectations for the focus on healthcare disparities resulting in meaningful change in 2022.
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
